Vlad Hogenhuis, MD, MBA

Dr. Vlad Hogenhuis, MD, MBA has an extensive work experience spanning several companies and roles. Vlad currently serves as the Chief Executive Officer of Chimera Bioengineering, where they lead the mission of using next-generation CAR T therapeutics to reprogram life and ultimately end cancer.

In addition to their role at Chimera Bioengineering, Dr. Hogenhuis serves as a Member of the Board of Directors for Rezolute, Inc., IHP Therapeutics, and GATT Technologies BV.

Prior to their current positions, Dr. Hogenhuis served as the Chief Operating Officer of Ultragenyx Pharmaceutical Inc. from September 2018 to June 2020. Before that, they held senior positions at GlaxoSmithKline, including SVP and Global Franchise Head of Specialty Care, and SVP and Global Franchise Lead of Cardiovascular, Metabolic, and Neurosciences.

Dr. Hogenhuis also held various roles at Merck, including Senior VP and Managing Director, Senior VP and Chief Marketing Officer, and Senior VP and General Manager. Vlad was responsible for global commercial activities and the commercialization of late-stage developmental products in Neuroscience, Dermatology, and Ophthalmology.

Earlier in their career, Dr. Hogenhuis worked as an Associate at McKinsey & Company and served as a Naval Lieutenant in the Royal Dutch Navy.

Furthermore, Dr. Hogenhuis has been involved in industry organizations and served as a Member of the Board of Directors for Pharma.be.

Overall, Dr. Vlad Hogenhuis has a diverse and extensive background in the pharmaceutical industry, leadership, and board participation.

Vlad Hogenhuis, MD, MBA, holds a Doctor of Medicine (MD) degree from Leiden University, where they studied medicine from 1982 to 1990. Before pursuing medicine, they attended Bischoppelijk college and Pius XII, although no specific degree is mentioned for these institutions. In 1990, they joined Tufts University School of Medicine as a Fellow to specialize in Outcomes Research. Following this, from 1992 to 1994, Vlad Hogenhuis attended The Wharton School to earn a Master of Business Administration (MBA) degree with a focus on Marketing/Marketing Management.